-
Forward Look
Aspirin Recommended to Reduce Colorectal Cancer RiskTask force formally recognizes the benefits, with caveats.
by Yasmine Iqbal
-
Forward Look
Fine-Tuning Treatments for Triple-Negative Breast CancerStudies aim to identify best available treatments and find new ones.
by Cameron Walker
-
Healthy Habits
Less StressCognitive-behavioral stress management may help women with breast cancer.
by Brenda Conaway
-
Survivor Profile
Living in the Here and NowA metastatic melanoma survivor is hopeful but realistic as new treatments become available.
by Jenny Song
-
Forward Look
Melanoma Risk Increased in Some Lymphoma SurvivorsStudy pinpoints group that may benefit from close surveillance.
by Sharon Reynolds
-
Survivor Profile
Changing CourseDuring her treatment for breast cancer, biomedical engineer Jessica Winter challenged her laboratory to bring its discoveries to patients more quickly.
by Chris Palmer
-
From the Editor-in-Chief
Early-Stage Prostate Cancer: To Treat or Not To TreatStrategies for prostate cancer screening and surveillance are still being refined.
by William G. Nelson, MD, PhD
-
Forward Look
Uterine Cancer Rates on the RiseStudy finds deaths are highest among African-American women.
by Brenda Conaway
-
Forward Look
Cancer Immunotherapies Continue to Make HeadwayDrugs that harness the power of the immune system gain new approvals.
by Alexandra Goho
-
Forward Look
Reducing Re-excisionNew guidelines and techniques aim to limit additional breast cancer surgeries.
by Kendall K. Morgan
While mRNA vaccines offer a personalized approach to triggering an immune response, peptide vaccines could be a one-size-fits-all treatment. Researchers are exploring both options.
by Thomas Celona
Declining Breast Cancer Mortality in Younger WomenU.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
Missed Activities Due to Cancer-related Fatigue and DepressionWomen were more likely than men to have fatigue or depression linked to cancer, and both effects were linked to people withdrawing from physical activities.
by Eric Fitzsimmons
Immunotherapy Improves Results in Head and Neck CancerCombining an immune checkpoint inhibitor with standard care extended event-free survival by nearly two years.
by Thomas Celona
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
